Streptozocin-based chemotherapy in patients with advanced pancreatic neuroendocrine tumors

被引：0
|
作者：
Pavel, Marianne E.
Dilz, Lisa-Marie
Denecke, Timm
Steffen, Ingo
Prasad, Vikas
Pape, Ulrich-Frank
Pascher, Andreas
Heetfeld, Maximilian
Wiedenmann, Bertram
机构：
[1] Charite, Dept Internal Med, D-13353 Berlin, Germany
[2] Charite Univ Med Ctr, Dept Radiol, Berlin, Germany
[3] Charite Univ Med Ctr, Dept Nucl Med, Berlin, Germany
[4] Charite, Dept Gen Visceral Vasc & Thorac Surg, D-13353 Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.295
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
295
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
    Lahner, Harald
    Mathew, Annie
    Klocker, Anna Lisa
    Unger, Nicole
    Theysohn, Jens
    Rekowski, Jan
    Joeckel, Karl-Heinz
    Theurer, Sarah
    Schmid, Kurt Werner
    Herrmann, Ken
    Fuehrer, Dagmar
    ENDOCRINE, 2022, 75 (01) : 293 - 302
  • [32] Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors
    Prakash, Laura
    Bhosale, Priya
    Cloyd, Jordan
    Kim, Michael
    Parker, Nathan
    Yao, James
    Dasari, Arvind
    Halperin, Daniel
    Aloia, Thomas
    Lee, Jeffrey E.
    Vauthey, Jean Nicolas
    Fleming, Jason B.
    Katz, Matthew H. G.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2017, 21 (01) : 155 - 163
  • [33] Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors
    Laura Prakash
    Priya Bhosale
    Jordan Cloyd
    Michael Kim
    Nathan Parker
    James Yao
    Arvind Dasari
    Daniel Halperin
    Thomas Aloia
    Jeffrey E. Lee
    Jean Nicolas Vauthey
    Jason B. Fleming
    Matthew H. G. Katz
    Journal of Gastrointestinal Surgery, 2017, 21 : 155 - 163
  • [34] Everolimus in the treatment of patients with advanced pancreatic neuroendocrine tumors: latest findings and interpretations
    Liu, Eric
    Marincola, Paula
    Oberg, Kjell
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2013, 6 (05) : 412 - 419
  • [35] Angiogenic Circulating Biomarkers in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus
    Cella, C. A.
    Spada, F.
    Labanca, V
    Radice, D.
    Rubino, M.
    Zorzino, L.
    Fazio, N.
    NEUROENDOCRINOLOGY, 2017, 105 : 3 - 3
  • [36] Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors
    Vernieri, Claudio
    Pusceddu, Sara
    de Braud, Filippo
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [37] Outcomes of Streptozotocin (STZ)-based chemotherapy (CT) in patients with advanced pancreatic neuroendocrine tumors (pNETs): Data from the Spanish Taskforce of Neuroendocrine and Endocrine Tumors (GETNE) national registry (R-GETNE)
    Esteban-Villarrubia, J.
    Hernando, J.
    Garcia, A.
    Jimenez-Fonseca, P.
    Teule, A.
    Garcia-Carbonero, R.
    Alonso, V
    Molina-Cerrillo, J.
    Paredes B, Garcia
    Herrero G, Crespo
    Capdevila, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 173 - 173
  • [38] Chemotherapy for advanced poorly differentiated pancreatic neuroendocrine carcinoma
    Ikeda, Masafumi
    Okuyama, Hiroyuki
    Takahashi, Hideaki
    Ohno, Izumi
    Shimizu, Satoshi
    Mitsunaga, Shuichi
    Kondo, Shunsuke
    Morizane, Chigusa
    Ueno, Hideki
    Okusaka, Takuji
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2015, 22 (08) : 623 - 627
  • [39] SunitinibIn Advanced, Well Differentiated Pancreatic Neuroendocrine Tumors
    Emma D. Deeks
    Eric Raymond
    BioDrugs, 2011, 25 : 307 - 316
  • [40] Emerging treatment modalities for advanced pancreatic neuroendocrine tumors
    Alessandro Sindoni
    Fausto Famà
    Maria Gioffre-Florio
    Sergio Baldari
    Hormones, 2016, 15 : 563 - 564
12345